RE:RE:RE:RE:Stock chartInteresting point on the ability of institutional investors to make sizeable investments. Sernova has too many shares already to want to do a pp at these low prices. And they will have all the cash they need for now with on hand, Evotec purchase and exercise of warrants. I suppose if the prospects are good enough institutions will find a way to invest but I agree with your comment on whether or not institutions will be interested in a mainly retail stock. You thought that an indication of institutions buying would be no price movement but heavy volume. Perhaps. But when that happens it is usually a sign of distribution. Not a good sign as people in the know are selling into the increased demand. I will hope increased demand, that also includes new retail, starts a steady upward progression in the stock price. A lot will depend on the FDA trial results June 6? We ain't the only game in town so these will be very important. Imho